Wistar Institute scientists find key piece in gene regulation puzzle

Philadelphia-- For the first time, scientists working in The Wistar Institute laboratory of Ronen Marmorstein, PhD, in collaboration with Shelley Berger, PhD, have determined the three-dimensional structure of a key enzyme involved in gene activation. In nature, this enzyme, which is called GCN5, functions to attach acetyl groups to histone proteins that are bound to DNA to facilitate gene activation. The Marmorstein group has obtained a structure of the histone acetyltransferase (HAT) domain of GCN5 bound to both its histone target and to its coenzyme-A cofactor. Details of this structure appear in the paper, "Crystal structure of Tetrahymena GCN5 with bound coenzyme-A and histone H3 peptide," in the September 2, 1999 issue of Nature.

Earlier this year, this same group of Wistar scientists solved the three-dimensional structure of two other HAT enzymes. The first structure, of PCAF, the human homologue of GCN5, bound to coenzyme-A, appeared in the July 1, 1999 issue of The EMBO Journal. The second structure, of yeast GCN5 in its unbound form, appeared along with editorial commentary in the August 3, 1999 issue of Proceedings of the National Academy of Sciences.

By comparing the structures of the unbound HAT, HAT bound to coenzyme-A and HAT bound to both coenzyme-A and histone, the Wistar group has gained valuable information about the mechanism of histone acetylation. In particular, they have identified the details of how the enzyme carries out its function, the structural adjustments the enzyme needs to make at each stage of its activities, and, most importantly, how it finds its histone target for proper regulation of gene activation.

Histones are proteins that bind to and restrict the activity of DNA in the chromosomes. Before the gene activation can occur, general transcription factor and coactivator proteins must bind to DNA and DNA and histones must be separated through a process that is facilitated by histone acetylation. Scientists

Contact: Diana Cutshall
The Wistar Institute

Page: 1 2 3

Related biology news :

1. Wistar-discovered antibody will help diagnose appendicitis
2. 2004 Wistar Institute Science Journalism Award winners announced
3. Call for Entries: The 2004 Wistar Institute Science Journalism Award
4. Wistar-developed antibody shows promise against brain tumors in Drexel trial
5. Wistar study offers new support for a histone code theory of gene regulation
6. Regeneration in the mammalian heart demonstrated by Wistar researchers
7. Wistar scientists add difficult-to-sequence stretches to human genome data
8. Wistar scientist receives award from National Cancer Institute
9. Director of Emory Vaccine Center to give Wistar Institutes 1999 Tadeusz J. Wiktor Memorial lecture
10. Wistar scientists find striking similarities between bacterial virus and human adenovirus
11. Wistar immunologists awarded grants to promote the development of vaccinesagainst HIV-1 and human papilloma viruses

Post Your Comments:

(Date:8/26/2020)... ... ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, is pleased to ... most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions made the Inc. ... growth of 71 percent. , The Inc. 5000 list represents a unique look ...
(Date:8/21/2020)... ... August 19, 2020 , ... “How can we help?”, asks ... Salivary Bioscience for more than twenty years. Together with Douglas Granger, Ph.D., founder ... Bioscience: Foundations of Interdisciplinary Saliva Research and Applications ," and Steven Granger, Ph.D., ...
(Date:8/12/2020)... , ... August 11, 2020 , ... ... based in Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI ... Both Roche and J&J have annual Research and Development spending in excess ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands ... , Known as MediVet Biologics since its formation in 2016, the company is ... Animal Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... the launch of its new tagline, “BUILDING FOR LIFE.” The adoption of this ... around the globe, requiring fast track capacity to provide patients with urgently needed ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... up to three different materials for use with CRM, neurostimulation, vascular, and related ... materials to meet specific design requirements, performance, and cost criteria; especially where solid ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management ... reasons it did not take off as quickly as people initially expected, and where ... towards capturing data electronically for clinical trials and then repurposing it for downstream analysis, ...
Breaking Biology Technology:
Cached News: